{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:47:06Z","timestamp":1774594026254,"version":"3.50.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular disease currently holds the highest morbidity and mortality rates globally. The survival of patients with coronary artery disease (CAD) complicated by chronic kidney disease (CKD) remains a significant threat, posing challenges in management and timely treatment. This study aims to explore the relationship between the Albumin-Corrected Anion Gap (ACAG) and the prognosis of patients with CKD Receiving Percutaneous Coronary Intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a single-center, retrospective study including 973 patients who underwent percutaneous coronary intervention (PCI) at Tianjin Medical University Second Hospital from January 2019 to June 2023, all with an estimated glomerular filtration rate (eGFR) of less than or equal to 60\u2005mL\/min\/1.73\u2005m\n                      <jats:sup>2<\/jats:sup>\n                      . Follow-up was completed in June 2023. The primary efficacy endpoint was the time-to-first occurrence of major adverse cardiovascular events (MACE), defined as the composite of cardiovascular death, recurrent myocardial infarction (MI), or non-fatal stroke. The key secondary endpoint was all-cause mortality, Additional secondary endpoints included (1) the individual components of the primary composite, (2) recurrent MACE (i.e., events after the first occurrence), and (3) any repeat revascularization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After a follow-up of 918.0\u2009\u00b1\u2009364.7 days, 205 MACEs were recorded. Receiver Operating Characteristic (ROC) curve analysis identified the optimal cutoff value for trial subjects. Compared to the low-ACAG group, the high-ACAG group exhibited a higher incidence of MACEs (29.65% vs. 15.78%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and all-cause mortality (29.92% vs. 11.96%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). The Kaplan\u2013Meier survival curve indicated that the low-ACAG group had a higher survival rate. Restricted cubic spline (RCS) analysis suggested that ACAG was positively correlated with MACE events. Univariate and multivariate Cox regression analysis indicated that a high ACAG level (HR: 1.820;95%CI: 1.300\u20132.546,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and the use of diuretics during hospitalization (HR: 1.653;95%CI: 1.195\u20132.286,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002) were independently associated with the occurrence of MACEs in patients with CAD and CKD. After adding ACAG and eGFR to the traditional risk model, Decision Curve Analysis (DCA) pointed out that DCA could improve the clinical net benefit within a certain range.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among patients undergoing PCI treatment for chronic kidney disease, elevated ACAG levels are closely related to the patient's cardiac mortality and all-cause mortality rates. Additionally, the use of diuretics in patients with CAD and CKD requires caution and should optimize treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1675923","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:18:57Z","timestamp":1774588737000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The prognostic value of albumin-corrected anion gap for major adverse cardiac events in chronic kidney disease patients undergoing percutaneous coronary intervention"],"prefix":"10.3389","volume":"13","author":[{"given":"Ziqiang","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Cardiology, Second Hospital of Tianjin Medical University","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Hospital of Tianjin Medical University","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahui","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Hospital of Tianjin Medical University","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangyin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Hospital of Tianjin Medical University","place":["Tianjin, China"]},{"name":"Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1097\/CM9.0000000000003270","article-title":"Burden of non-communicable diseases in China and its provinces, 1990\u20132021: results from the global burden of disease study 2021","volume":"137","author":"Liu","year":"2024","journal-title":"Chin Med J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/ehjqcco\/qcad033","article-title":"Burden of cardiovascular disease among elderly: based on the global burden of disease study 2019","volume":"10","author":"Qu","year":"2024","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.numecd.2024.03.024","article-title":"Association of cardiovascular health metrics with all-cause and cardiovascular disease mortality in chronic kidney disease: a cohort study","volume":"34","author":"Zhang","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1097\/CM9.0000000000003143","article-title":"Global burden of non-communicable diseases attributable to kidney dysfunction with projection into 2040","volume":"138","author":"Chen","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1681\/ASN.2017040422","article-title":"Metabolic acidosis and subclinical metabolic acidosis in CKD","volume":"29","author":"Raphael","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-024-00589-9","article-title":"Chronic kidney disease","volume":"11","author":"Romagnani","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"B8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.xkme.2021.04.011","article-title":"Metabolic acidosis and cardiovascular disease in CKD","volume":"3","author":"Collister","year":"2021","journal-title":"Kidney Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2416719","DOI":"10.1080\/0886022X.2024.2416719","article-title":"Association between albumin-corrected anion gap and kidney function in individuals with hypertension \u2013 NHANES 2009\u20132016 cycle","volume":"46","author":"Jiang","year":"2024","journal-title":"Renal Fail"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.2147\/JIR.S412860","article-title":"Albumin corrected anion gap and the risk of in-hospital mortality in patients with acute pancreatitis: a retrospective cohort study","volume":"16","author":"Li","year":"2023","journal-title":"J Inflamm Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"26006","DOI":"10.1038\/s41598-024-76324-x","article-title":"Association of albumin-corrected anion gap with severe consciousness disorders and outcomes in ischemic stroke: a retrospective MIMIC analysis","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"21510","DOI":"10.1038\/s41598-024-72703-6","article-title":"Increased serum albumin corrected anion gap levels are associated with poor prognosis in septic patients with liver cirrhosis","volume":"14","author":"Pan","year":"2024","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1053\/j.ajkd.2013.12.006","article-title":"GFR estimation: from physiology to public health","volume":"63","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1097\/00003246-199811000-00019","article-title":"Anion gap and hypoalbuminemia","volume":"26","author":"Figge","year":"1998","journal-title":"Crit Care Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2215\/CJN.03020906","article-title":"Serum anion gap: its uses and limitations in clinical medicine","volume":"2","author":"Kraut","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/j.ajkd.2021.02.341","article-title":"Approach to patients with high anion gap metabolic acidosis: core curriculum 2021","volume":"78","author":"Fenves","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ehf2.14639","article-title":"The correlation between albumin-corrected anion gap and prognosis in patients with acute myocardial infarction","volume":"11","author":"Sheng","year":"2024","journal-title":"ESC Heart Fail"},{"key":"B18","doi-asserted-by":"publisher","first-page":"117354","DOI":"10.1016\/j.cca.2023.117354","article-title":"Increased serum albumin corrected anion gap levels are associated with increased incidence of new-onset HF and poor prognosis in patients with acute myocardial infarction","volume":"544","author":"Zhao","year":"2023","journal-title":"Clin Chim Acta"},{"key":"B19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12872-025-04518-w","article-title":"Association of elevated albumin-corrected anion gap with all-cause mortality risk in atrial fibrillation: a retrospective study","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2282708","DOI":"10.1080\/0886022X.2023.2282708","article-title":"Association between albumin corrected anion gap and all-cause mortality in critically ill patients with acute kidney injury: a retrospective study based on MIMIC-IV database","volume":"45","author":"Gao","year":"2023","journal-title":"Renal Fail"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e081597","DOI":"10.1136\/bmjopen-2023-081597","article-title":"Relationship between the albumin-corrected anion gap and short-term prognosis among patients with cardiogenic shock: a retrospective analysis of the MIMIC-IV and eICU databases","volume":"14","author":"Wang","year":"2024","journal-title":"BMJ Open"},{"key":"B22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/0886022X.2021.1880936","article-title":"Optimal timing of coronary angiograms for patients with chronic kidney disease: association between the duration of kidney dysfunction and SYNTAX scores","volume":"43","author":"Song","year":"2021","journal-title":"Ren Fail"},{"key":"B23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s40520-018-0973-2","article-title":"Predisposing factors to heart failure in diabetic nephropathy: a look at the sympathetic nervous system hyperactivity","volume":"31","author":"Komici","year":"2019","journal-title":"Aging Clin Exp Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jacc.2018.12.015","article-title":"Best revascularization strategies in patients with CKD and DM: still uncertain","volume":"73","author":"Faxon","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.amjmed.2023.06.013","article-title":"Medical management of coronary artery disease in patients with chronic kidney disease","volume":"136","author":"Kim","year":"2023","journal-title":"Am J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00392-024-02452-z","article-title":"The significance of metabolic alkalosis on acute decompensated heart failure: the ALCALOTIC study","volume":"113","author":"Trull\u00e0s","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"B27","first-page":"87","article-title":"[Electrolyte and acid-base balance disorders in advanced chronic kidney disease]","volume":"28","author":"Alc\u00e1zar Arroyo","year":"2008","journal-title":"Nefrologia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCRESAHA.123.321752","article-title":"Endothelial cell dysfunction and increased cardiovascular risk in patients with chronic kidney disease","volume":"132","author":"Baaten","year":"2023","journal-title":"Circ Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2215\/CJN.14180920","article-title":"Management of heart failure patient with CKD","volume":"16","author":"Banerjee","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.ajkd.2021.09.029","article-title":"Diuretics in states of volume overload: core curriculum 2022","volume":"80","author":"Novak","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1080\/00325481.2024.2396796","article-title":"Thiazide diuretics versus loop diuretics in stage 3\u20135 CKD: impact on cardiorenal outcomes","volume":"136","author":"Sung","year":"2024","journal-title":"Postgrad Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1093\/ndt\/gfad118","article-title":"Hypertension in chronic kidney disease-treatment standard 2023","volume":"38","author":"Georgianos","year":"2023","journal-title":"Nephrol Dial Transplant"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1675923\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:18:58Z","timestamp":1774588738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1675923\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":32,"alternative-id":["10.3389\/fcvm.2026.1675923"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1675923","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"1675923"}}